Joanne Marie Bowen is an academic in the Adelaide Medical School at the University of Adelaide. She graduated with a PhD in Medicine from the University of Adelaide in December of 2006, having focused on the molecular control of chemotherapy-induced gastrointestinal tissue injury under the supervision of Professor Dorothy Keefe and Associate Professor Adrian Cummins. In January 2009, she was awarded an NHMRC Australian-based Biomedical Training Fellowship (2009–2012) to conduct research focused on the discovery of mRNA expression profiles associated with the risk of toxicity during treatment of oesophageal cancer under the supervision of Professor Richard Logan. This work was a novel approach to the discovery of peripheral blood biomarkers able to predict severe treatment toxicity and has led to numerous collaborations and awards. In 2011, she took up a lecturing position in Physiology and headed her research group, the Gastrointestinal Pathophysiology Laboratory, which is part of the internationally recognized Mucositis Research Group and the Centre for Personalised Cancer Medicine.
Research Keywords & Expertise
Survivorship
risk prediction
Precision Medicine
Host-Microbe Interacti...
Supportive cancer care
Personalised cancer ca...
Fingerprints
5%
risk prediction
Short Biography
Joanne Marie Bowen is an academic in the Adelaide Medical School at the University of Adelaide. She graduated with a PhD in Medicine from the University of Adelaide in December of 2006, having focused on the molecular control of chemotherapy-induced gastrointestinal tissue injury under the supervision of Professor Dorothy Keefe and Associate Professor Adrian Cummins. In January 2009, she was awarded an NHMRC Australian-based Biomedical Training Fellowship (2009–2012) to conduct research focused on the discovery of mRNA expression profiles associated with the risk of toxicity during treatment of oesophageal cancer under the supervision of Professor Richard Logan. This work was a novel approach to the discovery of peripheral blood biomarkers able to predict severe treatment toxicity and has led to numerous collaborations and awards. In 2011, she took up a lecturing position in Physiology and headed her research group, the Gastrointestinal Pathophysiology Laboratory, which is part of the internationally recognized Mucositis Research Group and the Centre for Personalised Cancer Medicine.